Psilocybin-Research.comSearchable psilocybin and psilocin bibliometric database.
Email alerts

Application overview

Source-labeled psilocybin and psilocin literature for search, monitoring, export, and citation workflows.

How the research index is built

Eight research sources feed Psilocybin-Research.com PubMed, OpenAlex, Crossref, Europe PMC, ClinicalTrials.gov, PsyArXiv, bioRxiv, and medRxiv provide records that are reconciled into the central research index. psilocybin-research.com PubMed OpenAlex Crossref Europe PMC ClinicalTrials.gov PsyArXiv bioRxiv medRxiv
Source records are fetched, reconciled, and labeled before appearing in the live index. The original sources remain authoritative.

Research workflow

Search, filter, export, analyze, and monitor publications with source labels, publication status, citation links, alerts, API access, and a rights-safe SQLite download. Read about the methods and limitations. Explore the dataset and reuse guide or research trends by year.

Published

Level of preparedness to use psilocybin among individuals seeking psychedelic risk reduction: a retrospective study of a pilot psychiatric consultation service

An abstract is available from the original source but is not redistributed by this tracker. Read the source record.

Open source BibTeX RIS

Bibliographic context

Journal
Frontiers in Public Health
Date
2026-09-16
Source
Crossref
DOI
10.3389/fpubh.2026.1921031
PubMed
Unavailable

Authors

Harrison Harland V.Gaillard MizanCook Ryan R.Sarparast AryanLevander Ximena A.
Watch author

Derived topics and classifications

psilocybin Review ArticleSafetyAdverse Events Review Article

Citation graph

38 referenced DOIs found in stored source metadata. 1 indexed paper cite this DOI.

Open citation network

10.1016/j.abrep.2022.10045410.1080/02791072.2024.240197710.1016/j.drugpo.2024.10450710.7326/annals-24-0314510.2147/dddt.s44317710.1016/j.jad.2025.12088210.1192/bjo.2025.1097410.1016/j.annemergmed.2023.11.00310.1080/02791072.2025.245447410.1001/jamapsychiatry.2022.410110.1177/0269881124125783910.1001/jamanetworkopen.2026.30608

Indexed papers citing this DOI

Level of preparedness to use psilocybin among individuals seeking psychedelic risk reduction: a retrospective study of a pilot psychiatric consultation service2026-09-16

Related papers

From Trials to Clinics: Considerations for Implementing Psychedelic-Assisted Therapy Into Clinical PracticePharmacology Research & Perspectives · 2026-05-10MedCheck: Psilocybin for Depression, LSD for Anxiety, Donanemab, LSD, and MorePsychiatric News · 2024-04-23Psychiatry & the psychedelic drugs. Past, present & future.Neuropharmacology · 2018-11-01Psychedelics and mental health: reimagining care through science, insight, and compassion.Frontiers in pharmacology · 2025-01-01